Danaher's $9.9B Acquisition of Masimo Approved by Shareholders, Awaiting Regulatory Clearance

2026Year5Month4Day,Medical Health Technology CompanyMasimo(Nasdaq Code:MASI) announced in a statement that,Its shareholders have voted to pass.Danaher(New York Stock Exchange code:DHR）The proposed acquisition offer.The transaction amount this time is99Billion USD，Equivalent to RMB676Hundred Million，Per Share180USD cash acquisition price, compared toMasimo 2Month10Premium of approximately25%。

According to both parties2The agreement reached in the month, headquartered in Irvine, CaliforniaMasimoTo be incorporated into Washington, D.C.DanaherDiagnostic Business Segment.After the transaction is completed,MasimoWill retain its brand and R&D system as an independently operated subsidiary, with its core product lines – including pulse oximeters,W1Medical-Grade Smartwatches and Remote Patient Monitoring Systems – To Be Directly Integrated IntoDanaherDigital health platform.DanaherThis acquisition will strengthen its layout in the precision medicine field, particularly forming a synergistic effect in chronic disease management and operating room solutions.

MasimoThe disclosed minutes of the shareholders' meeting show,5Month1At the virtual shareholders' meeting on [date], more than75%The shareholders of the circulating shares participated in the voting, among which98.3%In favor of the merger proposal. According to the terms of the deal, upon the effectiveness of the merger,MasimoExisting common shares will be automatically converted into each share180Cash rights in US dollars, with no interest and non-transferable. Notably, the transaction still requires approval by the US Federal Trade Commission (FTC) and the European Commission's antitrust review, and satisfy other customary closing conditions.MasimoChief Executive OfficerKatie SzymanIt was emphasized in the statement:"After the merger, we will focus onDanaherDiagnostic Segment Members Maintain Strategic Autonomy, Continuously Advancing Global Market Expansion and Technological Innovation.

If the transaction is completed successfully,DanaherThe proportion of revenue from the medical sector will increase to38%, becoming its largest business unit。Goldman Sachs healthcare industry analyst pointed out,MasimoContinuous monitoring technology andDanaherThe laboratory diagnostic equipment is complementary, especially with significant commercial value in intensive care and home care scenarios. However, some investors are concerned,99Whether the valuation of billions of dollars fully reflectsMasimoThe Growth Potential in the Wearable Medical Device Field – The CompanyW1Global smartwatch shipments increased year-over-year last year45%, accounting for18%。

As of5Month4Daily Close,MasimoStock Price Closing179.25Dollars, close to the acquisition price;DanaherStock Price Slightly Rises0.8%To284Dollars. Both parties expect the transaction to be completed by2026Completed in the fourth quarter of the year, or at the latest by2027Year3Month.

This major acquisition is of great significance toMasimoFor而言, it is the latest twist after several years of ups and downs.2024 Year, Founder and CEO Joe Kiani in 9 Resigned after the monthly shareholder vote, having been removed as chairman of the board during a prolonged proxy fight. By the end of the same year, the company's headquarters implemented layoffs.

2025Year,Masimo Appointing for the Long Term Edwards Critical Care Leader's Szyman Appointed as the new CEO. Under Szczepanik's leadership, the company has advanced the sale of its consumer audio business transaction,Shift the focus to medical technology, and 2025 Year 9 Monthly Completion 3.5 Billion-dollar deal, starting with 2022 Year 10 Billion-dollar acquisition Sound United Draw a full stop to the chapter.

At the same time,MasimoContinue the protracted legal battle with tech giant Apple. Recently, the company opposed Apple's appeal to overturn the ruling.Masimo Payment 6.34 The jury's verdict ordering Apple to pay billions in damages for infringing Masimo Pulse Oximeter Patent.

This acquisition is also one of the most strategically significant transactions for Danaher in recent years.Globally Recognized in the Medical Industry"King of M&A" Danaher has a wide range of business layouts in the healthcare field, and in the past 40 Completing hundreds of acquisitions annually, analysts expect it to be capable of funding this deal through a combination of cash and debt. Radiometer Medical, acquired by Danaher more than two decades ago, has monitoring systems that cover... Masimo Same technical parameters, and Radiometer Already Masimo SET Technology integration into some monitors, also in 2013 Year of Acquisition HermoCue Add real-time hemoglobin and blood glucose testing services. Therefore, analysts believeDHR Such potential deals may be aimed at deepening its layout in the patient monitoring field.

This acquisition by DanaherMasimoThe transaction, whether for both parties involved or for the entire medical industry, may have a profound impact. Instrument Family will continue to follow up on subsequent developments.